Document Detail


IGFBP-3 can either inhibit or enhance EGF-mediated growth of breast epithelial cells dependent upon the presence of fibronectin.
MedLine Citation:
PMID:  20851879     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Progression of breast cancer is associated with remodeling of the extracellular matrix, often involving a switch from estrogen dependence to a dependence on EGF receptor (EGFR)/HER-2 and is accompanied by increased expression of the main binding protein for insulin-like growth factors (IGFBP-3). We have examined the effects of IGFBP-3 on EGF responses of breast epithelial cells in the context of changes in the extracellular matrix. On plastic and laminin with MCF-10A normal breast epithelial cells, EGF and IGFBP-3 each increased cell growth and together produced a synergistic response, whereas with T47D breast cancer cells IGFBP-3 alone had no effect, but the ability of EGF to increase cell proliferation was markedly inhibited in the presence of IGFBP-3. In contrast on fibronectin with MCF-10A cells, IGFBP-3 alone inhibited cell growth and blocked EGF-induced proliferation. With the cancer cells, IGFBP-3 alone had no effect but enhanced the EGF-induced increase in cell growth. The insulin-like growth factor-independent effects of IGFBP-3 alone on cell proliferation were completely abrogated in the presence of an EGFR, tyrosine kinase inhibitor, Iressa. Although IGFBP-3 did not affect EGFR phosphorylation [Tyr(1068)], it was found to modulate receptor internalization and was associated with activation of Rho and subsequent changes in MAPK phosphorylation. The levels of fibronectin and IGFBP-3 within breast tumors may determine their dependence on EGFR and their response to therapies targeting this receptor.
Authors:
Jamie McIntosh; Godwin Dennison; Jeff M P Holly; Caroline Jarrett; Alexandra Frankow; Emily J Foulstone; Zoe E Winters; Claire M Perks
Related Documents :
1679089 - Influence of chloroquine and lidocaine on retention and cytotoxic effects of [131i]egf:...
2458359 - Two independent mechanisms for escaping epidermal growth factor-mediated growth inhibit...
11401499 - Rottlerin induces a transformed phenotype in human keratinocytes.
10470859 - Mannose 6-phosphate/insulin-like growth factor ii receptor mediates the growth-inhibito...
21046629 - Fate of retinoic acid-activated embryonic cell lineages.
19414339 - Development of targeted therapy with paclitaxel incorporated into egf-conjugated nanopa...
23973669 - Snail/beta-catenin signaling protects breast cancer cells from hypoxia attack.
11100819 - Suppression of cell invasion on human malignant glioma cell lines by a novel matrix-met...
2155419 - An immunohistochemical study of lung carcinomas using a monoclonal antibody which speci...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-09-17
Journal Detail:
Title:  The Journal of biological chemistry     Volume:  285     ISSN:  1083-351X     ISO Abbreviation:  J. Biol. Chem.     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-12-06     Completed Date:  2011-01-10     Revised Date:  2013-06-03    
Medline Journal Info:
Nlm Unique ID:  2985121R     Medline TA:  J Biol Chem     Country:  United States    
Other Details:
Languages:  eng     Pagination:  38788-800     Citation Subset:  IM    
Affiliation:
School of Clinical Sciences, IGFs and Metabolic Endocrinology Group, Learning and Research Building, 2nd Floor, University of Bristol, Southmead Hospital, Bristol BS10 5NB, United Kingdom.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Biotinylation
Breast / metabolism*
Breast Neoplasms / metabolism*
Cell Line, Tumor
Epidermal Growth Factor / metabolism*
Fibronectins / chemistry*
Gene Expression Regulation, Neoplastic*
Humans
Insulin-Like Growth Factor Binding Protein 3 / metabolism*
Laminin / chemistry
MAP Kinase Signaling System
Phosphorylation
Quinazolines / pharmacology
Radioimmunoassay
rho-Associated Kinases / metabolism
Chemical
Reg. No./Substance:
0/Fibronectins; 0/Insulin-Like Growth Factor Binding Protein 3; 0/Laminin; 0/Quinazolines; 62229-50-9/Epidermal Growth Factor; EC 2.7.11.1/rho-Associated Kinases; S65743JHBS/gefitinib
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Transcriptional repressor E4-binding protein 4 (E4BP4) regulates metabolic hormone fibroblast growth...
Next Document:  BMP2-activated Erk/MAP kinase stabilizes Runx2 by increasing p300 levels and histone acetyltransfera...